Maltese prescribers use of off-label and unlicensed medicines in children: perceptions and attitudes

被引:5
|
作者
Ellul, Ian [1 ]
Grech, Victor [1 ]
Attard-Montalto, Simon [1 ]
机构
[1] Univ Malta, Dept Paediat, Msida, Malta
关键词
Children; Malta; Off-label medicines; Prescribers; Unlicensed medicines; DRUG-USE; PEDIATRICIANS;
D O I
10.1007/s11096-016-0306-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Reviews of paediatric prescriptions in the community setting have quantified off-label use to reach 52 % and unlicensed use to reach 17 %. Objective To investigate the attitudes and perceptions of a sample of paediatricians and family doctors practising in primary care on off-label and unlicensed prescribing in children in Malta. Methods A validated de novo 18-item questionnaire was used to conduct face-to-face, semi-structured interviews with 24 family doctors and 6 paediatricians during 2014. Results Although only 10 % of participants correctly defined off-label/unlicensed use, after the definitions were provided, 97 % admitted to knowingly prescribe medicines in this manner. Such use primarily involved prescribing to younger age groups and different indications to those recommended in the product literature. The main contributing factor for prescribing in an off-label/unlicensed manner was a lack of appropriately licensed paediatric medicines. The most commonly implicated class of medicines was cough/cold medicines. The principal concerns were medico-legal and safety concerns. Conclusion Participants knowingly prescribed medicines in an off-label/unlicensed manner. The perceived reasons were prescribing for a younger age and for indications outside the Summary of Product Characteristics. Divergent prescribing recommendations in different sources of information, prescribers' personal experience and reliance on medical representatives contribute to inadvertent off-label/unlicensed prescribing.
引用
收藏
页码:788 / 792
页数:5
相关论文
共 50 条
  • [41] Unlicensed and off-label drug use: Issues and recommendations
    Conroy S.
    Pediatric Drugs, 2002, 4 (6) : 353 - 359
  • [42] Unlicensed and Off-Label Drug Use in ChildrenImplications for Safety
    Imti Choonara
    Sharon Conroy
    Drug Safety, 2002, 25 : 1 - 5
  • [43] Extent and nature of unlicensed and off-label medicine use in hospitalised children in Palestine
    Khdour, Maher R.
    Hallak, Hussein Othman
    Alayasa, Kawther Shab'an Atallah
    AlShahed, Qusai Nabeel
    Hawwa, Ahmed F.
    McElnay, James C.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (04) : 650 - 655
  • [44] Off-label and unlicensed use of antidotes in paediatric patients
    Lifshitz, M
    Gavrilov, V
    Gorodischer, R
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 56 (11) : 839 - 841
  • [45] Use of Off-Label and Unlicensed Drugs in Paediatrics: Review
    Joaquim, J. J.
    Fonseca, C. I.
    Romao, C. F.
    Pires, T. S.
    DRUG SAFETY, 2011, 34 (10) : 972 - 972
  • [46] Off-label and unlicensed use of antidotes in paediatric patients
    Matityahu Lifshitz
    Vladimir Gavrilov
    Rafael Gorodischer
    European Journal of Clinical Pharmacology, 2001, 56 : 839 - 841
  • [47] Parental views and attitudes towards use of unlicensed and off-label medicines in children and paediatric clinical trials: an online cross-sectional study in the Arab world
    Mukattash, Tareq L.
    Jarab, Anan S.
    Daradkeh, Aseel
    Abufarha, Rana
    AbuHammad, Sawsan H.
    AlRabadi, Nasr N.
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2019, 10 (03) : 333 - 339
  • [48] Off-Label Use of Medicines: Time for Action
    Gnjidic, D.
    Le Couteur, D. G.
    Hilmer, S. N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (02) : 157 - 157
  • [49] Off-Label and Unlicensed Prescribing of Medicines in Paediatric Populations: Occurrence and Safety Aspects
    Aagaard, Lise
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 117 (04) : 215 - 218
  • [50] OFF-LABEL AND UNLICENSED PRESCRIBING IN HOSPITALIZED CHILDREN: PREVALENCE AND REASONS
    Man, Sorin Claudiu
    Primejdie, Daniela Petruta
    Sarkozi, Ingrid-Krisztina
    Popa, Adina
    FARMACIA, 2017, 65 (03) : 460 - 466